Avricore Health

What Avricore Health does

Avricore Health Inc. is a Vancouver-based, TSX Venture-listed (TSX-V: AVCR) digital health company whose flagship product, the HealthTab platform, delivers point-of-care testing infrastructure to community pharmacies. HealthTab combines rapid diagnostic devices — sourced through partnerships with instrument manufacturers such as Abbott and Ascensia — with a secure cloud-based system for viewing, tracking, and integrating test results. The platform supports on-site screening for up to 27 biomarkers, including HbA1c for diabetes management, plus bacterial and viral testing for Strep and COVID-19. APIs enable integration with hospital systems and third-party applications, including Patients Know Best for patient-controlled records.

The company monetizes HealthTab through hardware and consumable sales to pharmacies and through a recurring platform/usage-based component tied to network scale. Distribution is concentrated through enterprise partnerships: Rexall in Canada and Barts Health NHS Trust in the UK, where the platform has been deployed across community pharmacies in North East and North Central London. A British Heart Foundation grant (~£198,000 / ~$385,000 CAD) funds an Inclisiran cholesterol-lowering secondary-prevention pilot, expanding the use case from screening to therapeutic administration and long-term lipid management.

Avricore is at an early commercialization stage. The UK pilot has screened more than 3,500 patients across 57 pharmacy locations and reported a 10x per-location throughput uplift versus prior Canadian operations. The published 'Path Forward' roadmap targets 500+ active UK pharmacy locations by mid-2027, with a longer-term addressable market of 10,000+ community pharmacies across 42 NHS England integrated care boards. The company is publicly traded on TSX-V (AVCR) and OTCQB (AVCRF), has 11-50 employees, and most recently raised CAD $1,254,000 in a non-brokered private placement in June 2026 with proceeds earmarked for UK expansion and working capital.

Name

Avricore Health

Legal name

Avricore Health Inc.

Website

https://avricorehealth.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

Avricore Health provides the HealthTab point-of-care testing platform, combining rapid diagnostic devices with cloud-based results management for community pharmacies and NHS systems across Canada and the UK.

Ownership category

akta.pro rank

Product category

Pharmacy Point-of-Care Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industries

Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• Point-of-care testing
• Pharmacy clinical services
• Chronic disease screening
• Real-world evidence data
• Diagnostic platform software

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Point-of-Care Device and Consumable Sales: Revenue from partnership with instrument manufacturers and pharmacy point-of-care testing network. Hardware and testing consumables sold through pharmacy network.
2. HealthTab Platform Subscription/Licensing: Cloud-based platform delivered to pharmacy network customers, generating recurring revenue from clinical testing services infrastructure.
3. HealthTab Network Expansion Services: Proceeds designated to expand HealthTab pharmacy point-of-care testing network. Revenue model tied to network scale and testing volume.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Avricore Health sells the HealthTab point-of-care testing platform to community pharmacies and NHS healthcare systems. The platform combines rapid diagnostic devices capable of testing up to 27 biomarkers for chronic disease screening (e.g., diabetes HbA1c) and bacterial/viral testing (Strep and COVID-19) with a secure cloud-based system for viewing and tracking results, API-based integration with third-party applications, and real-world evidence data capture for healthcare programs and clinical trials.

Product overview

Avricore Health operates as a single unified product platform through HealthTab, its flagship point-of-care testing solution. HealthTab enables community pharmacies to perform on-site diagnostic testing for chronic conditions and infectious diseases, with results managed through a cloud-based system. The platform also supports real-world evidence gathering and custom reporting for healthcare programs and clinical trials.

Differentiator

Problem solved

Functional benefit

Brands

• HealthTab: A point-of-care testing platform for pharmacy that can test up to 27 biomarkers on the spot for screening and managing chronic conditions such as diabetes, as well as bacterial and viral testing for Strep and COVID-19. The platform combines rapid testing with a secure, cloud-based system for viewing and tracking results.

Products and services

• HealthTab Point-of-Care Testing Platform HealthTab is a point-of-care testing platform deployed in community pharmacies and NHS settings that tests up to 27 biomarkers on-site for screening and managing chronic conditions such as diabetes (HbA1c) and performs bacterial and viral testing including Strep and COVID-19. It pairs lab-accurate rapid diagnostic instruments with a secure cloud-based system for viewing and tracking results, enables API integration with third-party applications and electronic health records, and generates real-time deidentified patient data that can be customized into reports for healthcare programs and clinical trials. The platform is sold to community pharmacy operators and NHS healthcare systems to expand clinical services and support decentralized chronic disease management.

Quantifiable outcome

• 3,500+ patients screened across UK community pharmacies in pilot phase
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core, major, flagship and minor.

• AbbottcoreTechnology or IntegrationAbbott is a leading point-of-care device manufacturer and strategic partner for HealthTab. Abbott's diagnostic instruments power the rapid testing capabilities of the HealthTab platform, enabling lab-accurate results for chronic disease screening.
• Ascensia Diabetes CarecoreTechnology or IntegrationAscensia Diabetes Care is a point-of-care device manufacturer partner providing instruments for diabetes-related testing within the HealthTab platform network.
• RexallmajorChannel Partner/ Reseller/ DistributorRexall pharmacy chain partnership deploying HealthTab point-of-care testing in Canadian community pharmacies, enabling expanded clinical services for patients.
• Barts Health NHS TrustflagshipStrategic or Co-development PartnerMajor NHS trust partnership deploying HealthTab for pharmacy point-of-care testing pilot across North East and North Central London. Includes integration with hospital systems for long-term lipid management and cardiovascular secondary prevention.
• North East London Community PharmacymajorChannel Partner/ Reseller/ DistributorCommunity pharmacy network partner in NHS pilot expansion across North East London, part of the UK expansion roadmap targeting 500+ pharmacy locations.
• Heart UKminorStrategic or Co-development PartnerCharitable partner focused on cholesterol awareness and cardiovascular health, supporting Inclisiran secondary prevention pilot program within the pharmacy network.
• UCLPartnersminorStrategic or Co-development PartnerNHS-affiliated healthcare organization providing independent evaluation of the Inclisiran secondary prevention pilot program within the HealthTab pharmacy network.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/avricore

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avricore Health